We supposed that up-regulation of FATP5 would predict prognosis in CRC more accurately, suggesting the crucial role of FATP5 as a novel diagnostic biomarker in this aggressive carcinoma, by regulating the cell cycle G2/M transition. This evidence concerns the gene SLC27A5 and colorectal carcinoma.